Logo

American Heart Association

  10
  0


Final ID: Sun202

Post-resuscitation Sedation with Dexmedetomidine during Targeted Normothermia Enhances EEG Recovery and Improves Survival in Mice

Abstract Body: Introduction: Neurological recovery after cardiac arrest (CA) remains poor. While majority of comatose post-arrest patients are sedated, its benefits under normothermia remain unclear. This study examined whether sedation improves outcomes after resuscitation under normothermic conditions.
Hypothesis: Post-CA sedation modulates cerebral physiology and improves neurological outcomes in normothermic mice.
Methods: Adult male C57BL/6J mice underwent CA induced by potassium chloride injection and were resuscitated after 10 minutes. Mice were randomized into five groups: control (normothermia without sedation); dexmedetomidine (2 μg/kg/h), ketamine (10 mg/kg/h), or propofol (2 mg/kg/h) sedation under normothermic conditions; and a hypothermia group without sedation. Sedatives were administered subcutaneously via osmotic pumps for 24 hours starting 10 minutes post-resuscitation. In the control and sedation groups, esophageal temperature was maintained at 36°C for 2 hours during oxygenation via tracheal intubation. After extubation, mice were placed in cages and maintained at 33°C with rectal temperature for 4 more hours, then housed at 33°C for up to 48 hours. The hypothermia group was kept 3°C lower for the first 6 hours, then at 30°C. EEGs were recorded continuously for 48 hours using implanted telemetry transmitters.
Results: Dexmedetomidine sedation significantly improved 10-day survival under normothermia (3/11 vs. control 1/11; P = 0.021), while ketamine and propofol showed no benefit (ketamine: 1/11, P = 0.96; propofol: 2/11, P = 0.091) compared to normothermia control without sedation. Hypothermia without sedation markedly improved survival (6/11 vs. 1/11; P = 0.0034). Dexmedetomidine and propofol accelerated recovery from EEG suppression and enhanced gamma-band activity at 6 hours, suggesting better cortical recovery. In contrast, hypothermia suppressed EEG activity during the first 6 hours. Body temperature regulation differed significantly: mice in the control and ketamine groups experienced a rapid rise in body temperature after 6 hours shortly before their death, while temperature remained relatively stable in the dexmedetomidine and hypothermia groups.
Conclusion: Dexmedetomidine improved survival under normothermia, possibly through both neurophysiological and thermoregulatory mechanisms. In contrast, ketamine did not yield benefits. Post-resuscitation sedation may improve outcomes by optimizing neurophysiological recovery.
  • Sugimoto, Yuki  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Miyazaki, Yusuke  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Ikeda, Takamitsu  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Ichinose, Fumito  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Yuki Sugimoto: DO NOT have relevant financial relationships | Yusuke Miyazaki: DO NOT have relevant financial relationships | Takamitsu Ikeda: DO NOT have relevant financial relationships | Fumito Ichinose: No Answer
Meeting Info:

Resuscitation Science Symposium 2025

2025

New Orleans, Louisiana

Session Info:

Basic Science (Drug intervention)

Sunday, 11/09/2025 , 01:30PM - 03:00PM

ReSS25 Poster Session and Reception

More abstracts from these authors:
NETosis Attenuating Nanoprobe Improves Survival after Cardiac Arrest

Chen Howard, Boukhalfa Asma, Hayashida Kei, Miyazaki Yusuke, Pal Rahul, Yuan Hushan, Kumar Anand, Ichinose Fumito, Sosnovik David

Mentor

Kim Edy, Ichinose Fumito

You have to be authorized to contact abstract author. Please, Login
Not Available